Nomura Holdings’s Fortress Biotech FBIO Stock Holding History

Nomura Holdings’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,000	Closed	-$313K	–	2833
2014 Q1	$313K	Buy	+10,000	New	+$390K	﹤0.01%	2059

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's FBIO Position: Q2 2016 in Review

Nomura Holdings sold out of Fortress Biotech (FBIO) in Q2 2016, closing a stake of 1,418 shares — an estimated $67K sold.

Nomura Holdings first reported a position in FBIO in Q1 2014 and held it in 2 quarters. The position peaked at $67K in Q1 2016. 52 funds tracked by Wall St. Rank hold FBIO as of Q2 2016.

Nomura Holdings reported no remaining Fortress Biotech position as of Q2 2016 after selling out during the quarter.
Nomura Holdings sold 1,418 Fortress Biotech shares in Q2 2016, an estimated $67K.
Nomura Holdings first reported a position in Fortress Biotech in Q1 2014 and held it in 2 quarters.
Nomura Holdings's Fortress Biotech position peaked at $67K in Q1 2016.
52 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.